首页> 美国卫生研究院文献>EBioMedicine >A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections
【2h】

A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections

机译:一种新颖的多重qPCR测定法用于检测多克隆感染中富含组氨酸的蛋白2和3(pfhrp2和pfhrp3)缺失的恶性疟原虫

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many health facilities in malaria endemic countries are dependent on Rapid diagnostic tests (RDTs) for diagnosis and some National Health Service (NHS) hospitals without expert microscopists rely on them for diagnosis out of hours. The emergence of lacking the gene encoding histidine-rich protein 2 and 3 (HRP2 and HRP3) and escaping RDT detection threatens progress in malaria control and elimination. Currently, confirmation of RDT negative due to the deletion of and , which encodes a cross-reactive protein isoform, requires a series of PCR assays. These tests have different limits of detection and many laboratories have reported difficulty in confirming the absence of the deletions with certainty.
机译:疟疾流行国家的许多医疗机构都依靠快速诊断检测(RDT)进行诊断,而一些没有专业显微镜专家的国家卫生服务(NHS)医院则在数小时内不依靠它们进行诊断。缺乏编码富含组氨酸的蛋白质2和3(HRP2和HRP3)的基因以及逃脱RDT检测的出现威胁着疟疾控制和消除的进展。当前,由于编码交叉反应蛋白同工型的和的缺失而导致RDT阴性的确认需要一系列PCR分析。这些测试具有不同的检测限,许多实验室已报告难以确定缺失的缺失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号